findmyKOL
Clinical trialNCT02786810CompletedPhase 2Interventional

Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

SponsorUniversity of TennesseeEnrollment10Urinary Tract InfectionVesicoureteral Reflux
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Tennessee Health Science Center

    Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Sulfur hexafluoride (lipid-type A microspheres)
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2016
Primary completion
30 Nov 2016
Completion
30 Nov 2016
Last update posted
11 May 2018
Registered enrollment
10
Registry id
NCT02786810
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.